New Drugs in Cancer Chemotherapy

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Oncology
Cover of the book New Drugs in Cancer Chemotherapy by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642815652
Publisher: Springer Berlin Heidelberg Publication: March 9, 2013
Imprint: Springer Language: English
Author:
ISBN: 9783642815652
Publisher: Springer Berlin Heidelberg
Publication: March 9, 2013
Imprint: Springer
Language: English

The Analog Potential in Cancer Chemotherapy in the United States and Japan S. K. Carter Northern California Cancer Program, 1801 Page Mill Road, Building B, Suite 200, USA - Palo Alto, CA 94304 The bilateral collaborative program in cancer research between Japan and the United States is one of the oldest programs of this type. It is sponsored in the United States by the National Cancer Institute [1], while in Japan the sponsoring organization is the Japan Society for the Promotion of Science. Annual symposia concerning treatment have been held and in recent years they have been published [2, 3]. Drug development in both Japan and the United States has evolved over the years to an increasing emphasis on second generation compounds. This has come about as a result of the initial successes of chemotherapy development. Many active structures have been uncovered and the armamentarium of the medical and pediatric oncologist has grown dramatically. The uncovering of an active structure provides an opportunity for analog synthesis and attempts at elucidating structure-activity relationships. It is hoped that the therapeutic index of active structures can be improved so as to achieve superior clinical results.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The Analog Potential in Cancer Chemotherapy in the United States and Japan S. K. Carter Northern California Cancer Program, 1801 Page Mill Road, Building B, Suite 200, USA - Palo Alto, CA 94304 The bilateral collaborative program in cancer research between Japan and the United States is one of the oldest programs of this type. It is sponsored in the United States by the National Cancer Institute [1], while in Japan the sponsoring organization is the Japan Society for the Promotion of Science. Annual symposia concerning treatment have been held and in recent years they have been published [2, 3]. Drug development in both Japan and the United States has evolved over the years to an increasing emphasis on second generation compounds. This has come about as a result of the initial successes of chemotherapy development. Many active structures have been uncovered and the armamentarium of the medical and pediatric oncologist has grown dramatically. The uncovering of an active structure provides an opportunity for analog synthesis and attempts at elucidating structure-activity relationships. It is hoped that the therapeutic index of active structures can be improved so as to achieve superior clinical results.

More books from Springer Berlin Heidelberg

Cover of the book Stochastische Risikomodellierung und statistische Methoden by
Cover of the book Reconstructive Plastic Surgery of Pressure Ulcers by
Cover of the book Lithosphere Dynamics and Sedimentary Basins: The Arabian Plate and Analogues by
Cover of the book Medienstrafrecht by
Cover of the book Molecular Mechanisms in Legionella Pathogenesis by
Cover of the book Landslide Science and Practice by
Cover of the book Handbook of Digital Homecare by
Cover of the book The Human Substantia Nigra and Ventral Tegmental Area by
Cover of the book Graph-Theoretic Concepts in Computer Science by
Cover of the book Electromyography and Evoked Potentials by
Cover of the book Genetik by
Cover of the book Static Analysis by
Cover of the book Arthroscopic Management of Distal Radius Fractures by
Cover of the book Revolution im Profifußball by
Cover of the book Ocular Infections by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy